Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Becatecarin in Refractory Ovarian Cancer
NCT00006262Phase 2Terminated
- Sponsor
- Northwestern University
- Start
- Jul 2000
- Primary completion
- Sep 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of becatecarin in ovarian cancer, sponsored by Northwestern University. Started Jul 2000; status: terminated.
02
Drugs
becatecarin
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT00006262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006262.